Aeluma (NASDAQ:ALMU) Issues Earnings Results

Aeluma (NASDAQ:ALMU) announced its quarterly earnings results on Wednesday. The company reported ($0.15) earnings per share (EPS) for the quarter, FiscalAI reports. Aeluma had a negative net margin of 115.57% and a negative return on equity of 12.03%. The company had revenue of $0.58 million during the quarter.

Here are the key takeaways from Aeluma’s conference call:

• Aeluma is prioritizing commercialization in AI datacom, focusing on its Lynx high-speed photodetectors and Quasar quantum-dot lasers for scale-up and scale-out data-center interconnects. Management cited strong anticipated industry demand and customer interest driven by photonics supply constraints.
• The company signed an agreement with Sumitomo Chemical Advanced Technologies to expand wafer-production capacity and plans to install multiple AIXTRON MOCVD systems, supporting higher-volume manufacturing of its non-indium-phosphide technologies.
• Aeluma is negotiating several multimillion-dollar commercial NRE programs, primarily with top-tier AI-datacom customers. It also has a letter of intent for up to $30 million in CHIPS R&D funding, which management expects would accelerate commercialization, although the funding would likely be recorded as a government equity investment rather than revenue.
• Fiscal 2026 revenue was $4.5 million, roughly flat year over year, while the GAAP net loss widened to $9.2 million from $3.0 million as headcount and operating expenses increased. Fiscal 2027 booked government-contract revenue is expected to be approximately $2.3 million, with additional revenue uncertain.
• Aeluma ended the year with $56 million in cash and no debt after raising $20.1 million through its ATM facility, but expects to spend approximately $10 million–$12 million in fiscal 2027 capital expenditures on MOCVD equipment and manufacturing scale-up.

Aeluma Price Performance

NASDAQ:ALMU opened at $13.43 on Thursday. The firm has a 50-day moving average of $15.24 and a two-hundred day moving average of $17.98. The stock has a market cap of $245.90 million, a P/E ratio of -38.37 and a beta of 4.07. Aeluma has a 1-year low of $10.24 and a 1-year high of $31.79.

More Aeluma News

Here are the key news stories impacting Aeluma this week:

• Positive Sentiment: Potential CHIPS Act funding: Aeluma signed a letter of intent for up to $30 million in CHIPS funding to support artificial intelligence and advanced-computing initiatives. The funding is not yet guaranteed, but it could help finance the company’s planned growth. Aeluma expects fiscal 2027 capital expenditures of approximately $10 million to $12 million. Aeluma outlines up to $30M CHIPS funding path while planning $10M-$12M fiscal 2027 capex
• Positive Sentiment: Sumitomo Chemical agreement: Aeluma expanded its relationship with Sumitomo Chemical Advanced Technologies to accelerate development, qualification and production of photonics wafers for AI datacom. The arrangement initially uses Sumitomo’s Phoenix, Arizona, MOCVD facilities and provides a path to greater capacity. Aeluma’s use of gallium arsenide and silicon substrates could reduce reliance on scarce and expensive indium phosphide. Aeluma Announces Fourth Quarter and Full Fiscal Year 2026 Financial Results
• Neutral Sentiment: Strategic growth opportunity: Management is positioning Aeluma’s scalable photonics platform for AI, datacom, defense, aerospace, mobile and quantum applications. However, the announcements primarily describe planned development and future capacity rather than near-term revenue commitments. Aeluma Q4 2026 earnings call transcript
• Negative Sentiment: Continuing losses and limited revenue: Fiscal fourth-quarter revenue was only $0.58 million, while adjusted earnings were a loss of $0.15 per share. Aeluma reported a negative net margin of 115.57% and negative return on equity, underscoring its lack of current profitability. Planned capital spending could also increase cash needs before commercial scale is achieved. Aeluma quarterly earnings results

Insider Activity

In related news, Director Steven Denbaars sold 12,500 shares of the business’s stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $13.84, for a total value of $173,000.00. Following the transaction, the director owned 357,709 shares in the company, valued at approximately $4,950,692.56. The trade was a 3.38% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 14.70% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Aeluma in a research note on Friday, July 17th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Aeluma presently has a consensus rating of “Moderate Buy” and an average target price of $25.00.

About Aeluma

Aeluma, Inc is a semiconductor company that develops and manufactures high-performance components for communications, sensing, computing and other advanced technology applications. The company’s technology is designed to support the production of semiconductor devices on large-area and nontraditional substrates, with the goal of improving performance, scalability and integration.

Aeluma’s products and development efforts include photonic and optoelectronic components such as photodetectors and related devices used in optical communications, data centers, 3D sensing, artificial intelligence, aerospace and defense, automotive systems, and consumer electronics.